ORAMED PHARMACEUTICALS INC (ORMP) Stock Cash Flow
NASDAQ:ORMP - Nasdaq - US68403P2039 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -28.28M | -19.10M | 5.09M | -37.76M | -22.99M | |||
| Depreciation Amortization | 167.00K | 193.00K | 196.00K | 60.00K | 80.00K | |||
| Change In Working Capital | 2.25M | 3.20M | -2.70M | -940.00K | -1.32M | |||
| Interest Paid | 1.75M | 2.32M | 574.00K | N/A | N/A | |||
| Taxes Paid | N/A | N/A | 0.00 | 100.00K | 100.00K | |||
| Other non cash items | 15.40M | 7.30M | -12.88M | 10.73M | 3.05M | |||
| OPERATING CASH FLOW | -10.46M | -8.41M | -10.29M | -27.92M | -21.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -19.00K | -18.00K | -254.00K | -500.00K | -380.00K | |||
| Other Investing Activity | 99.45M | 105.83M | -72.78M | 30.71M | -23.39M | |||
| INVESTING CASH FLOW | 99.44M | 105.82M | -73.04M | 30.21M | -23.76M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -49.55M | 49.55M | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | -2.48M | 2.43M | 11.56M | 101.39M | |||
| Other Financing Activity | N/A | -2.00K | N/A | -780.00K | 1.50M | |||
| FINANCING CASH FLOW | N/A | -52.04M | 51.98M | 10.78M | 102.89M | |||
| Exchange Rate Effect | -4.00K | -4.00K | -54.00K | -60.00K | 0.00 | |||
| CHANGE IN CASH | 55.94M | 45.37M | -31.41M | 13.01M | 57.95M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.46M | -8.41M | -10.29M | -27.92M | -21.18M | |||
| Capital Expenditure | -19.00K | -18.00K | -254.00K | -500.00K | -380.00K | |||
| FREE CASH FLOW | -10.47M | -8.43M | -10.55M | -28.42M | -21.56M | |||
All data in USD